Boston Therapeutics, Inc.
BTHE · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,384 | $3,960 | $47 | $7 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $2 |
| Other Curr. Assets | $164 | $145 | $4 | $10 |
| Total Curr. Assets | $2,548 | $4,106 | $50 | $20 |
| Property Plant & Equip (Net) | $342 | $202 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $122 | $60 | $0 | $0 |
| Total NC Assets | $465 | $262 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,012 | $4,367 | $50 | $20 |
| Liabilities | – | – | – | – |
| Payables | $854 | $1,428 | $313 | $531 |
| Short-Term Debt | $548 | $1,198 | $1,148 | $4,835 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $294 | $294 | $105 | $105 |
| Other Curr. Liab. | $2,019 | $1,520 | $1,484 | $3,129 |
| Total Curr. Liab. | $3,714 | $4,440 | $3,049 | $8,600 |
| LT Debt | $0 | $1,604 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3,231 | $16,037 | $964 | $0 |
| Total NC Liab. | $3,231 | $17,641 | $964 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6,946 | $22,080 | $4,013 | $8,600 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $917 | $917 | $917 | $111 |
| Retained Earnings | -$104,589 | -$102,114 | -$42,045 | -$28,014 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $84,104 | $83,485 | $37,165 | $19,323 |
| Total Equity | -$19,568 | -$17,713 | -$3,962 | -$8,580 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | -$12,622 | $4,367 | $50 | $20 |
| Net Debt | -$1,836 | -$1,159 | $1,101 | $4,828 |